Skip to main content

View full-text article in PMC

. 2022 Dec 5;87:104386. doi: 10.1016/j.ebiom.2022.104386

Table 5.

Comparison of neutralizing antibody against Omicron between Pfizer mRNA booster and SCV01C booster.

					SCTV01C booster^d
	PRNT50 (GMT)	Pfizer mRNA booster			Low baseline	Medium baseline	High baseline	Overall
	PRNT50 (GMT)	N = 20²⁶	N = 20²⁷	N = 20²⁸	N = 16	N = 35	N = 107	N = 158
Delta	Pre-booster	86	NA		40	238	1505	946
	Post-booster	2315^a			2560	4413	3765	3816
	Fold-change	26.9			64	18.6	2.5	4
Omicron	Pre-booster	35	5	13	14	57	369	175
	Post-booster	628^a	67^b	336^c	698	580	963	833
	Fold-change	17.9	13	25	49.4	10.1	2.6	4.7

GMT = Geometric Mean Titer.

^a

Tested at 2–3 weeks after the booster dose.

^b

Tested at 28 days after the booster dose.

^c

Tested at 1 month after the booster dose.

^d

Tested measured at 28 days after the booster dose.